Here's Why PetMed (PETS) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pets at Home results ‘highly unlikely to help' valuation, says Peel Hunt
Pets at Home Group PLC (LSE:PETS)'s first-half profit before tax exceeded Peel Hunt's forecasts today, although the broker acknowledged that a full-year profit downgrade will offset the perceived positives. “The shares are not on a big valuation, in our view, but have not had any positive forecast for a while and this is highly unlikely to help,” said analysts.
Pets at Home shares drop 8% after profit downgrade and Budget hit
Shares in Pets at Home Group PLC (LSE:PETS) fell 8% in early trading after the company lowered its full-year profit guidance. The retailer blamed subdued growth in the pet retail market, which it now expects to persist through the second half of its financial year.
Here's Why PetMed (PETS) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
PetMed Express: Why (And Why Not) The Rebound Could Continue
PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance.
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed (PETS) Surpasses Q2 Earnings Estimates
PetMed (PETS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to break-even earnings per share a year ago.
Here's Why PetMed (PETS) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PetMed Express, Inc. (PETS) Q1 2025 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS ) Q1 2025 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Reed Anderson - Investor Relations, ICR Sandra Campos - Chief Executive Officer & President Christine Chambers - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Operator Greetings and welcome to PetMed Express First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Pets at Home's veterinary offering drives revenue growth
Pets at Home Group PLC (LSE:PETS) is seeing a noticeable increase in average spend and visits for its veterinary services, which is helping to offset a decline in retail spend. Vet Group revenues surged more than 17% in the first half of its 2025 financial year, leading to a 1% growth in group-wide revenues to £441.1 million despite a 0.8% dip in retail sales.
